Literature DB >> 14400597

Studies on fluorinated pyrimidines. XI. In vitro studies on tumor resistance.

C HEIDELBERGER, G KALDOR, K L MUKHERJEE, P B DANNEBERG.   

Abstract

Entities:  

Keywords:  NEOPLASMS/experimental; PYRIMIDINES/metabolism

Mesh：

Substances：

Year:  1960        PMID： 14400597

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  18 in total

1.  Comparison of 5-FU versus FUDR activity in human colorectal cancer using an in vitro clonogenic assay (HTCA).

Authors:  M Flentje; D Flentje; P Schlag
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  The inhibitory effects of 5-fluorouracil on the metabolism of preribosomal and ribosomal RNA in L-1210 cells in vitro.

Authors:  R Kanamaru; H Kakuta; T Sato; C Ishioka; A Wakui
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  Determinants of human tumor sensitivity to fluorinated pyrimidine chemotherapy.

Authors:  W H Wolberg
Journal:  Ann Surg       Date:  1967-10       Impact factor: 12.969

4.  Synthesis of thymine and alpha-putrescinylthymine in bacteriophage phi W-14-infected Pseudomonas acidovorans.

Authors:  K L Maltman; J Neuhard; H A Lewis; R A Warren
Journal:  J Virol       Date:  1980-05       Impact factor: 5.103

Review 5.  The fluoropyrimidines: biochemical mechanisms and design of clinical trials.

Authors:  M A Friedman; W Sadée
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

6.  In vitro sensitivity test of stomach cancer tissues by the use of metal grid method.

Authors:  S Fujimoto; T Akao; B Itoh; Y Kitsukawa; M Takahashi; K Itoh
Journal:  Jpn J Surg       Date:  1979-12

Review 7.  [On the problem of praetherapeutic sensitivity testing of human tumours based on incorporation studies of nucleic acid precursors in vitro (author's transl)].

Authors:  S Seeber; C G Schmidt
Journal:  Klin Wochenschr       Date:  1977-12-01

8.  Effects of uracil and thymidine on the development of resistance to 5-fluorouracil in Pediococcus cerevisiae.

Authors:  P J WHITE; C A NICHOL
Journal:  J Bacteriol       Date:  1963-01       Impact factor: 3.490

9.  Pharmacokinetics of 5-fluorouracil: inter-relationship with biochemical kinetics in monitoring therapy.

Authors:  W Sadee; C G Wong
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

10.  5-Fluorouracil's cytotoxicity is enhanced both in vitro and in vivo by concomitant treatment with hyperthermia and dipyridamole.

Authors:  Y Maehara; Y Sakaguchi; I Takahashi; M Yoshida; H Kusumoto; H Masuda; K Sugimachi
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.